1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea

C52H80N4O18S — CID 147741728

IUPAC1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea
SMILESC[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2NC(=O)NCS(=O)(=O)C1=CCC=N1
InChIInChI=1S/C52H80N4O18S/c1-31-18-15-13-11-9-7-5-6-8-10-12-14-16-19-38(73-50-49(66)45(53)48(65)34(4)72-50)27-42-46(56-51(67)55-30-75(69,70)43-20-17-23-54-43)41(62)29-52(68,74-42)28-37(59)25-40(61)39(60)22-21-35(57)24-36(58)26-44(63)71-33(3)32(2)47(31)64/h5-16,18-20,23,31-42,45-50,57-62,64-66,68H,17,21-22,24-30,53H2,1-4H3,(H2,55,56,67)/b6-5+,9-7+,10-8+,13-11+,14-12+,18-15+,19-16+/t31-,32-,33-,34+,35+,36+,37-,38-,39+,40+,41-,42-,45-,46+,47+,48+,49-,50-,52+/m0/s1
InChIKeyHALNVECZVMMXOI-XJSBGGLASA-N
MW1081.29 g/mol
LogP0.37
Rot. Bonds6

About 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea

1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea (PubChem CID 147741728) has the molecular formula C52H80N4O18S and a molecular weight of 1081.29 g/mol. Its IUPAC name is 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea.

Molecular Properties

Compound Name1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea
PubChem CID147741728
Molecular FormulaC52H80N4O18S
Molecular Weight1081.29 g/mol
Exact Mass1080.52
IUPAC Name1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea
SMILESC[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2NC(=O)NCS(=O)(=O)C1=CCC=N1
InChIInChI=1S/C52H80N4O18S/c1-31-18-15-13-11-9-7-5-6-8-10-12-14-16-19-38(73-50-49(66)45(53)48(65)34(4)72-50)27-42-46(56-51(67)55-30-75(69,70)43-20-17-23-54-43)41(62)29-52(68,74-42)28-37(59)25-40(61)39(60)22-21-35(57)24-36(58)26-44(63)71-33(3)32(2)47(31)64/h5-16,18-20,23,31-42,45-50,57-62,64-66,68H,17,21-22,24-30,53H2,1-4H3,(H2,55,56,67)/b6-5+,9-7+,10-8+,13-11+,14-12+,18-15+,19-16+/t31-,32-,33-,34+,35+,36+,37-,38-,39+,40+,41-,42-,45-,46+,47+,48+,49-,50-,52+/m0/s1
InChIKeyHALNVECZVMMXOI-XJSBGGLASA-N
XLogP0.37
TPSA369.94 Ų
H-Bond Donors13
H-Bond Acceptors20
Rotatable Bonds6
Heavy Atoms75
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001081.29
LogP ≤ 50.37
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1020

Analyze 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea?
The IUPAC name of 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea (CID 147741728) is 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea.
What is the SMILES notation for 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea?
The canonical SMILES for 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea is C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2NC(=O)NCS(=O)(=O)C1=CCC=N1.
What is the InChIKey of 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea?
The InChIKey is HALNVECZVMMXOI-XJSBGGLASA-N. The full InChI is InChI=1S/C52H80N4O18S/c1-31-18-15-13-11-9-7-5-6-8-10-12-14-16-19-38(73-50-49(66)45(53)48(65)34(4)72-50)27-42-46(56-51(67)55-30-75(69,70)43-20-17-23-54-43)41(62)29-52(68,74-42)28-37(59)25-40(61)39(60)22-21-35(57)24-36(58)26-44(63)71-33(3)32(2)47(31)64/h5-16,18-20,23,31-42,45-50,57-62,64-66,68H,17,21-22,24-30,53H2,1-4H3,(H2,55,56,67)/b6-5+,9-7+,10-8+,13-11+,14-12+,18-15+,19-16+/t31-,32-,33-,34+,35+,36+,37-,38-,39+,40+,41-,42-,45-,46+,47+,48+,49-,50-,52+/m0/s1.
What are the key properties of 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea?
1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea has a molecular weight of 1081.29 g/mol, XLogP of 0.37, 6 rotatable bonds, 13 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(3H-pyrrol-5-ylsulfonylmethyl)urea is sourced from PubChem (CID 147741728), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).